We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
124.00 | 1.03% | 12,186.00 | 12,184.00 | 12,186.00 | 12,266.00 | 12,054.00 | 12,194.00 | 184,986 | 10:26:22 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.72 | 188.91B |
Date | Subject | Author | Discuss |
---|---|---|---|
19/6/2021 11:12 | BBC News - Coronavirus: Setback for EU in legal fight with AstraZeneca EU delivery schedule would appear to be unreasonable? | stutes | |
18/6/2021 16:57 | A good result since both sides can claim they won and the EU Commission can save face. | pdt | |
18/6/2021 14:35 | P, What a waste of EU taxpayers money, obviously the court ruled in AZ favour. There was no contract only 'Best Efforts' how many times were the EU told! Now. What compensation are AZ going to go for? | beckers2008 | |
18/6/2021 13:54 | Blow for Brussels as EU loses court case against Oxford vaccine maker | philanderer | |
15/6/2021 09:53 | RE above post - some recent movement in this sector - The US government has agreed to purchase $1.2 billion worth of an experimental COVID-19 treatment from Merck if the drug is approved by regulators. This purchase would provide enough medication to fully treat 1.7 million people with the new drug. Molnupiravir, which is currently in Phase 3 clinical trials, is being tested on study participants who have been diagnosed with COVID-19, aren't hospitalized and have one or more risk factors, such as diabetes, obesity or old age, associated with worse outcomes from the disease. A big sector. | alphorn | |
13/6/2021 23:22 | Data is now coming out regarding vaccinated people catching the Delta strain PHE now say it is 64% more transmissible indoors than the UK strain and 40% more transmissible outdoors Yet UK pubs and eateries remain open ?? Over 90% of new cases in the UK are now Delta and one SAGE Prof has just forecast 100,000 cases a day if we carry on the way we are Suspending 'freedom day' which imo was a badly flawed concept for 4 weeks in the present semi open format will not work. 64 Countries now have Delta cases and it has doubled case numbers in the USA in the last week This is the worst variant strain yet by far More vaccinations are needed now even for those with two doses Delays between doses is now also a flawed concept due to only 33% efficacy A more rigorous lockdown is the only answer BUT getting one now after 'freedom day' expectations is going to be a very hard sell. Variants are getting worse not better as many scientists had predicted would be the case They are coming at a rate of one dominant new world strain every 4 months This means a new vaccine specific to each variant needs to be made in 100 days like the new chief scientific advisor to Biden has recently stated. Mask wearing on public transport looks set to made permanent from this day forwards OR until clean disinfected air is provided dyor imo | buywell3 | |
10/6/2021 09:30 | Haven't posted on here for a while, but I have two questions for others to mull over if they so choose: 1. AZN originally flagged July 2021 as what they would term 'the end of the pandemic' and therefore when they would start making a margin on the Covid vaccine sales. Given that's just a couple of weeks away now, and with immunity in developed nations going reasonably well, has anyone read or heard on the grapevine whether this is still their planned date for this? 2. Secondly, what are people's predictions for when shareholders might see a dividend increase, given its been held at the same level for some years now? Great that they've maintained this in the meantime, but it would be nice to see that yield go up sometime in the future ... TIA | bluemango | |
10/6/2021 08:54 | Breakout! Everyone loves a bullish momentum breakout, onwards & upwards Nice reverse H&S playing out now | ny boy | |
09/6/2021 21:33 | Can't see any bad news in that article. Benefits outway the risks. | gregb | |
09/6/2021 19:53 | bad news announcement and AZN share price rockets - hard to understand the market at times ! | arja | |
09/6/2021 09:53 | S, Keep winding the poor person (whoevervthat may be?) up. Lol, just lol! | beckers2008 | |
08/6/2021 15:27 | Doubt they have not got them yet. | montyhedge | |
04/6/2021 10:41 | Most will have sold already | smcni1968 | |
04/6/2021 08:39 | All good news, it's a shame shares will come off when bid finalised.What will Alexion shareholders do with they Astra shares. To me that's the uncertainty. | montyhedge | |
04/6/2021 01:48 | Yep, good news. SMCNI1968 - you should have an 'Edit' button for another time? | bluemango | |
04/6/2021 00:02 | *wouldn't* want to be Monty, that should be | smcni1968 | |
04/6/2021 00:01 | Positive results for Lynparza in breast cancer would want to be Monty tomorrow | smcni1968 | |
03/6/2021 10:37 | Merger should complete second half of the year, what I understand Alexion shareholders end up with 15% of Astra, wonder what they will do, sell or hold? | montyhedge | |
02/6/2021 15:10 | Moments ago, BBC News: Gov Minister singing the praises of PS and AstraZeneca. Bodes well for the future. | beckers2008 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions